INVIDIA CAPITAL MANAGEMENT, L.P.

INVIDIA CAPITAL MANAGEMENT, L.P. is a Series C+ and buyout fund in the US investing in Healthcare, pharma-services, devices-diagnostics, regulatory-consulting, hc-it, payor-provider-tech, data-access, interoperability, virtual-care, pharmacy-services, multi-site-providers, efficiency-technology, home-care, retail-healthcare, primary-care, animal-health and womens-health.

Stages: Series C+, buyout
Sectors: Healthcare, pharma-services, devices-diagnostics, regulatory-consulting, hc-it, payor-provider-tech, data-access, interoperability, virtual-care, pharmacy-services, multi-site-providers, efficiency-technology, home-care, retail-healthcare, primary-care, animal-health, womens-health
Invests in: US-wide
Round role: Leads rounds
Actively investing: Yes
Founded: 2024
Assets under management: $150.4M

Check size not disclosed

Thesis

Invidia Capital Management, L.P. is a private equity firm founded in 2024 and based in New York City, focusing exclusively on the healthcare sector. Invidia actively engages in value creation through team building, technology transformation, go-to-market strategies, and M&A. They are also committed ESG investors. While generally seeking majority control, they are open to active minority investments. The firm reported $150.4 million in AUM as of April 21, 2026, and is targeting $850 million for its inaugural fund, Invidia Curie Fund I, with a minimum investment of $5 million. Key subsectors include Supporting R&D Innovation, Tech-Enabled Services, Delivery Transformation, and Consumer-Oriented Healthcare.

Common questions

Does INVIDIA CAPITAL MANAGEMENT, L.P. invest at the Series C+ stage?

Yes. INVIDIA CAPITAL MANAGEMENT, L.P. lists Series C+ and buyout among the stages it invests in.

Where does INVIDIA CAPITAL MANAGEMENT, L.P. invest?

INVIDIA CAPITAL MANAGEMENT, L.P. invests in the US.